NIKKEI 225
38,799.77 -120.49 (-0.31%) HANG SENG
19,433.14 +56.61 (+0.29%) CRUDE OIL
79.36 +0.13 (+0.16%) GOLD FUTURES
2,382.20 -3.30 (-0.14%) DOW
39,869.38 -38.62 (-0.10%) Bitcoin GBP
51,757.74 -250.22 (-0.48%)
Biotech and drug stocks
7.45k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop speciality drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three-month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called ‘Battling Cancer’.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Biotech and drug stocks | -0.13% | - | - | - |
| ^GSPC | -0.21% | +5.47% | +27.37% | +5595.81% |
31 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 771.12 | -15.90 | -2.02% | 16:00 GMT-4 | 2.30M | 2.81M | 732.88B |
| NVO | Novo Nordisk A/S | 133.04 | -1.62 | -1.20% | 16:00 GMT-4 | 2.88M | 4.62M | 593.52B |
| JNJ | Johnson & Johnson | 154.28 | +1.61 | +1.05% | 16:00 GMT-4 | 6.92M | 7.47M | 371.30B |
| MRK | Merck & Co., Inc. | 130.88 | -0.85 | -0.65% | 16:00 GMT-4 | 5.22M | 8.22M | 331.49B |
| ABBV | AbbVie Inc. | 164.35 | +0.56 | +0.34% | 16:00 GMT-4 | 4.29M | 5.62M | 290.22B |
| AZN | AstraZeneca PLC | 77.04 | +0.07 | +0.09% | 16:00 GMT-4 | 2.75M | 5.52M | 238.86B |
| RHHBY | Roche Holding AG | 32.65 | +1.25 | +3.98% | 16:00 GMT-4 | 5.30M | 2.88M | 210.45B |
| NVS | Novartis AG | 102.69 | -0.53 | -0.51% | 16:00 GMT-4 | 807.28k | 1.62M | 209.91B |
| AMGN | Amgen Inc. | 314.72 | -2.07 | -0.65% | 16:00 GMT-4 | 2.37M | 2.78M | 168.83B |
| PFE | Pfizer Inc. | 28.92 | +0.10 | +0.35% | 16:01 GMT-4 | 34.30M | 42.74M | 163.88B |
| SNY | Sanofi | 48.82 | -0.19 | -0.39% | 16:00 GMT-4 | 1.96M | 2.01M | 122.39B |
| VRTX | Vertex Pharmaceuticals Incorporated | 440.64 | +3.15 | +0.72% | 16:00 GMT-4 | 1.22M | 1.02M | 113.71B |
| REGN | Regeneron Pharmaceuticals, Inc. | 967.98 | -10.23 | -1.05% | 16:00 GMT-4 | 386.50k | 456.51k | 106.66B |
| GSK | GlaxoSmithKline plc | 44.88 | -0.44 | -0.98% | 16:00 GMT-4 | 3.51M | 3.17M | 94.23B |
| BMY | Bristol-Myers Squibb Company | 44.11 | -0.44 | -0.99% | 16:00 GMT-4 | 15.44M | 15.38M | 89.42B |
| GILD | Gilead Sciences, Inc. | 67.86 | +0.85 | +1.27% | 16:00 GMT-4 | 4.75M | 7.02M | 84.54B |
| ZTS | Zoetis Inc. | 173.71 | +0.43 | +0.25% | 16:00 GMT-4 | 1.69M | 3.72M | 79.26B |
| MRNA | Moderna, Inc. | 132.68 | +3.62 | +2.80% | 16:00 GMT-4 | 2.93M | 3.84M | 50.85B |
| TAK | Takeda Pharmaceutical Company Limited | 13.31 | -0.08 | -0.60% | 16:00 GMT-4 | 1.19M | 1.66M | 41.77B |
| HLN | Haleon plc | 8.37 | -0.04 | -0.48% | 16:00 GMT-4 | 13.37M | 6.52M | 38.22B |
| BIIB | Biogen Inc. | 230.04 | -5.28 | -2.24% | 16:00 GMT-4 | 901.13k | 1.25M | 33.49B |
| BAYRY | Bayer Aktiengesellschaft | 7.77 | -0.25 | -3.06% | 16:00 GMT-4 | 2.01M | 2.09M | 30.65B |
| BNTX | BioNTech SE | 92.98 | +0.78 | +0.85% | 16:00 GMT-4 | 389.05k | 593.01k | 22.41B |
| ARGX | argenx SE | 376.6 | -0.36 | -0.10% | 16:00 GMT-4 | 148.35k | 274.09k | 22.38B |
| BGNE | BeiGene, Ltd. | 171.03 | +6.15 | +3.73% | 16:00 GMT-4 | 253.59k | 212.88k | 19.40B |
| GMAB | Genmab A/S | 29.65 | -0.57 | -1.89% | 16:00 GMT-4 | 585.20k | 533.29k | 19.15B |
| ALNY | Alnylam Pharmaceuticals, Inc. | 151.22 | +3.82 | +2.59% | 16:00 GMT-4 | 836.42k | 674.00k | 19.13B |
| TEVA | Teva Pharmaceutical Industries Limited | 16.3 | -0.48 | -2.86% | 16:00 GMT-4 | 15.89M | 10.19M | 18.90B |
| ALPMY | Astellas Pharma Inc. | 9.68 | -0.12 | -1.22% | 15:54 GMT-4 | 241.18k | 331.49k | 17.58B |
| RPRX | Royalty Pharma plc | 27.88 | -0.12 | -0.43% | 16:00 GMT-4 | 2.93M | 2.76M | 16.66B |
Yahoo Finance UKBest UK savings accounts that offer above inflation rates
See the best savings accounts to find a top-rated deal that works for you.
Yahoo Finance UK9 houses with great-looking gardens
Check out these houses for sale if inspiring outside space tops your property wish list.
PR NewswireFDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy. IMDELLTRA has received accelerated approval based on the encouraging response rate and duration of response (DoR) observed in clinical studies. Continued approval for this indication may be contingent upon verificatio
